Texting Moms-to-Be: a simple way to tame diabetes in pregnancy?
NCT ID NCT03025984
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether sending text message reminders and education to pregnant women with diabetes helps them follow their care plan—like keeping appointments, tracking blood sugar, and taking medications. About 185 participants will be randomly assigned to receive texts or standard care. The goal is to see if this low-tech approach can improve health for both mother and baby.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- text message reminders and education system
- What this could lead to
- If it works, this could offer a simple, low-cost way to help pregnant women with diabetes manage their condition better, potentially reducing complications.
- What could go wrong
- This is a behavioral study, not a drug trial, so the effect may be modest. Results depend on participants' engagement and may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
185 people
The number who actually took part.
- Started
-
Dec 2016
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. The patient is a pregnant person 18 years of age or older 2. The patient has been diagnosed with gestational diabetes or is a patient with known diabetes and a confirmed viable pregnancy 3. The pregnancy has a singleton pregnancy 4. The patient has access to a cellular phone with a text messaging plan Exclusion Criteria: 1. The patient does not have a cellular phone 2. The patient becomes hospitalized for a pregnancy complication for the remainder of pregnancy 3. The fetus has a chromosomal or non-chromosomal malformation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Mary's Health Center
St Louis, Missouri, 63117, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill takes aim at stubborn blood sugar
- Gene therapy shots aim to save legs from amputation in diabetes
- New pill takes aim at blood sugar in diabetes
- Can coconut oil and moringa rinses fight gum disease in diabetic kids?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Eye scans as a window to the body: study probes retinal imaging across diseases